Policy & Medicine

Maryland PDAB Releases Draft Action Plan for Establishing UPLs

Thomas Sullivan Nov 20, 2024 0

Maryland’s Prescription Drug Affordability Board (PDAB) released its draft action plan for establishing upper payment limits (UPLs) for drugs identified as causing (or likely to cause) affordability shortages. In the draft action plan, the state outlines the process for whether a UPL should be set, and if so, the amount. The Maryland PDAB is a…

Policy and Medicine Compliance Update – November 2023…

Thomas Sullivan Dec 1, 2023 0

Policy and Medicine Compliance Update October 2023 Issue…

Thomas Sullivan Oct 20, 2023 0

Maryland PDAB Releases Draft Action Plan for Establishing UPLs

Drug Distributors Agree to Pay $300 Million to Health Plans

The nation’s three largest drug distributors – McKesson Corp, Cardinal Health Inc, and Cencora Inc – recently agreed to pay $300 million to health plans to settle lawsuits over their role in the…

FTC Sues PBMs and GPOs For Anti-Competitive Rebate Practice

The United States Federal Trade Commission (FTC) filed an administrative complaint against the nation’s three largest prescription drug benefit managers (PBMs) – Caremark Rx, Express Scripts (ESI),…

Unlocking the Fatty Liver Mistry: The Silent Threat of Fatty…

In the inaugural episode of "Unlocking the Fatty Liver Mistry," Dr. Neeraj Mistry, Chief Medical Officer of the Fatty Liver Foundation, shares crucial insights on the often-overlooked health…

Oncology Unscripted with John Marshall, MD: Are You Overdosing…

In the latest episode of Oncology Unscripted, Dr. John Marshall addresses critical issues concerning the dosing practices in oncology, particularly questioning the prevailing approach of using maximum…

Updates from FDA’s Office of Prescription Drug Promotion:…

In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, the Director of the Office of Prescription Drug Promotion (OPDP) at the…

Walgreens Reaches $106.8 Million False Claims Act Settlement…

Walgreens Boots Alliance Inc. and Walgreen Co. (collectively, “Walgreens”) agreed to pay $106.8 million in two settlements (here and here) to resolve allegations that Walgreens violated the False…

Reevaluating the RUC Committee: Addressing Specialty…

With the new administration and congress coming, one simple reform to increase the number of primary care physicians and reduce healthcare costs is updating the Relative Value Units (RVU) system. The…

Acadia Healthcare Reaches $19.85 Million Settlement to Resolve…

Acadia Healthcare Company, Inc., has reached a settlement agreement with the United States Department of Justice (DOJ) to resolve allegations that it violated the False Claims Act and certain state…

CVS Subsidiary Reaches $60 Million Settlement Over False Claims…

Oak Street Health, a wholly-owned subsidiary of CVS Health since 2023, has agreed to pay $60 million to resolve allegations that it violated the False Claims Act (FCA) by paying kickbacks to third…

Announcing the Launch of the This Week in Policy and Medicine…

We are excited to announce the debut of the This Week in Policy and Medicine Podcast, a weekly series that brings you the latest insights and analyses from the intersection of healthcare policy and…

What a Trump Presidency Could Mean for the Life Sciences…

With Donald Trump now confirmed as the President-elect, the life sciences industry is bracing for significant policy shifts that could impact everything from drug pricing to regulatory practices.…